Top

Breast Cancer Research and Treatment

Published in:

01-02-1998

Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention

Author: Michael N. Pollak

Published in: Breast Cancer Research and Treatment | Issue 3/1998

Title: Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention
Author: Michael N. Pollak
Publication date: 01-02-1998
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 3/1998
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1005950916707

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/1998

Igf system components as prognostic markers in breast cancer

Author index, Volume 47

The insulin-like growth factors and breast cancer — revisited

Igf-independent regulation of breast cancer growth by IGF binding proteins

Structure and function of the insulin-like growth factor I receptor

The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene

Keynote webinar | Spotlight on antibody–drug conjugates in cancer